Top Markets
Coin of the day
MOLOGEN Lifescience AG MOLOGEN Lifescience AG

MOLOGEN Lifescience AG

U1DA
Rank in Stocks #40050
Finchain Capital Partners AG functions as an investment firm, concentrating its... Finchain Capital Partners AG functions as an investment firm, concentrating its capital deployment on early-stage companies, specifically during their seed, Series A, and Series B funding rounds. The company was established on February 27, 2015, and is based in Dusseldorf, Germany.
Share Price
$3.32
Market Cap
$261.55K
Change (1 day)
0.00%
Change (1 year)
42.54%
Country
DE
Trade MOLOGEN Lifescience AG (U1DA)
Revenue for MOLOGEN Lifescience AG (U1DA)
Revenue in Aug 2026 TTM: 0
According to MOLOGEN Lifescience AG latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for MOLOGEN Lifescience AG from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$27.30B -
US
$16.04B -
US
- -
SE
$21.12B -
US
$5.45B -
US